Pediatrix Medical Group Inc(MD) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | RUT | P/E | 13.85 | EPS (ttm) | 2.08 | Insider Own | 1.59% | Shs Outstand | 81.2M | Perf Week | 2.71% |
| Market Cap | 2.34B | Forward P/E | 11.81 | EPS next Y | 3.99% | Insider Trans | -2.71% | Shs Float | 80.0M | Perf Month | 11.22% |
| Enterprise Value | 2.56B | PEG | 1.66 | EPS next Q | 0.65 | Inst Own | 103.8% | Short Float | 5.47% | Perf Quarter | 7.89% |
| Income | 0.17B | P/S | 1.2 | EPS this Y | 15.09% | Inst Trans | -0.13% | Short Ratio | 5.83 | Perf Half Y | 25.61% |
| Sales | 1.95B | P/B | 2.66 | EPS next 5Y | 7.11% | ROA | 8.26% | Short Interest | 4.37M | Perf YTD | 34.83% |
| Book/sh | 10.85 | P/C | 5.8 | EPS past 3/5Y | 34.98% - | ROE | 20.39% | 52W High | -4.01% ($30.05) | Perf Year | 65.37% |
| Cash/sh | 4.97 | P/FCF | 10.25 | Sales past 3/5Y | -0.99% 1.99% | ROIC | 13.42% | 52W Low | 70.65% ($16.90) | Perf 3Y | 154.77% |
| Dividend Est. | - | EV/EBITDA | 9.7 | EPS Y/Y TTM | 63.72% | Gross Margin | 25.05% | Volatility(W/M) | 3.72% 2.93% | Perf 5Y | 4.64% |
| Dividend TTM | - | EV/Sales | 1.31 | Sales Y/Y TTM | 0.51% | Oper. Margin | 12.34% | ATR (14) | 0.82 | Perf 10Y | -52.64% |
| Dividend Ex-Date | - | Quick Ratio | 1.32 | EPS Q/Q | 6.62% | Profit Margin | 8.96% | RSI (14) | 65.19 | Recom | 2.71 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.32 | Sales Q/Q | 4.04% | SMA20 | 5.99% ($27.21) | Beta | 0.65 | Target Price | $26.33 |
| Payout | - | Debt/Eq | 0.7 | Earnings | 2026/10/29 | SMA50 | 7.79% ($26.76) | Rel Volume | 0.89 | Prev Close | $29.04 |
| Employees | 6575 | LT Debt/Eq | 0.48 | EPS/Sales Surpr. | 6.6% 1.94% | SMA200 | 21.36% ($23.76) | Avg Volume(3M) | 0.75M | Price | $28.84 |
| IPO | 1995/9/20 | Option/Short | Yes/Yes | Trades | 6053 | Volume | 668,479 | Change | -0.69% |
👶 This is a US medical group that provides specialized healthcare services for newborns, expectant mothers, and pediatric patients. Backed by a team of specialist physicians, the company delivers care across neonatal intensive care, obstetrics and fetal medicine, and pediatric specialty services through partnerships with hospitals, and operates a nationwide network of medical specialists. It has established itself as a dedicated provider of specialized healthcare services focused on the newborn, maternal, and pediatric segments.
Over the past 1 year, on the higher side
4% below its 1-year high.
Traded about as much as usual. That is 89% of its average volume.
Next earnings report: October 29
1 days to go.
MD makes money exceptionally well
Of every $100 in sales, $12.34 is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +15.1% this year.
Tap to view numbers
The price is about the industry average
For a company earning $100 a year, you would pay $1,385. Peers typically go for $2,127. It is about in line with its own 4-year average.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 4 quarters.
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Hold.
Tap to view numbers
Holding long would have paid off
Bought 5 years ago, your return today would be +4.6%. The S&P 500 did +70% over the same period.
Tap to view numbers
No dividend
It reinvests profits in the business instead of paying dividends.
Ownership looks stable
Institutions hold 103.8%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
Special products that amplify (leveraged) or invert this single stock. They decay quickly and are not for long-term holding.
It ranks #18 of 48 in the industry
Based on market cap of $2B.
FAQ
What kind of company is MD?
MD belongs to the Healthcare sector and operates in the Medical Care Facilities industry.
What is the market cap of MD?
The market cap of MD is approximately $2.3B, ranking 1,936 within its sector.
What is the P/E ratio of MD?
MD has a P/E ratio of approximately 13.8x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for MD?
MD has recorded a 52-week high of $30.05 and a low of $16.90.